MX2013008197A - Sales de aminas organicas de azilsartan, metodo de preparacion y uso de las mismas. - Google Patents

Sales de aminas organicas de azilsartan, metodo de preparacion y uso de las mismas.

Info

Publication number
MX2013008197A
MX2013008197A MX2013008197A MX2013008197A MX2013008197A MX 2013008197 A MX2013008197 A MX 2013008197A MX 2013008197 A MX2013008197 A MX 2013008197A MX 2013008197 A MX2013008197 A MX 2013008197A MX 2013008197 A MX2013008197 A MX 2013008197A
Authority
MX
Mexico
Prior art keywords
azilsartan
preparation
organic amine
amine salts
disclosed
Prior art date
Application number
MX2013008197A
Other languages
English (en)
Other versions
MX340590B (es
Inventor
Baohai Yang
Bigao Pan
Longbin Huang
Original Assignee
Jiangsu Hanson Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jiangsu Hanson Pharmaceutical Co Ltd filed Critical Jiangsu Hanson Pharmaceutical Co Ltd
Publication of MX2013008197A publication Critical patent/MX2013008197A/es
Publication of MX340590B publication Critical patent/MX340590B/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4245—Oxadiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C213/08—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton by reactions not involving the formation of amino groups, hydroxy groups or etherified or esterified hydroxy groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/02—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C215/04—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated
    • C07C215/06—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated and acyclic
    • C07C215/08—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated and acyclic with only one hydroxy group and one amino group bound to the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/02—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C215/40—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton with quaternised nitrogen atoms bound to carbon atoms of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Se dan a conocer sales de aminas orgánicas de azilsartán, un método de preparación y uso del mismo. En particular, se dan a conocer sales de aminas orgánicas de azilsartán, su método de preparación, la composición farmacéutica que comprende compuesto en una cantidad terapéuticamente efectiva, y su uso para la fabricación de medicamentos antihipertensivos.
MX2013008197A 2011-01-20 2012-01-11 Sales de aminas organicas de azilsartan, metodo de preparacion y uso de las mismas. MX340590B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201110022311 2011-01-20
PCT/CN2012/070219 WO2012097697A1 (zh) 2011-01-20 2012-01-11 阿齐沙坦有机胺盐及其制备方法和用途

Publications (2)

Publication Number Publication Date
MX2013008197A true MX2013008197A (es) 2013-11-22
MX340590B MX340590B (es) 2016-07-13

Family

ID=46515148

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2013008197A MX340590B (es) 2011-01-20 2012-01-11 Sales de aminas organicas de azilsartan, metodo de preparacion y uso de las mismas.

Country Status (13)

Country Link
US (1) US9233954B2 (es)
EP (1) EP2666773B1 (es)
JP (1) JP5981940B2 (es)
CN (1) CN102603723B (es)
AU (1) AU2012208863B2 (es)
BR (1) BR112013017982A2 (es)
CA (1) CA2824316C (es)
HK (1) HK1169826A1 (es)
MX (1) MX340590B (es)
RU (1) RU2600986C2 (es)
TW (1) TWI519531B (es)
WO (1) WO2012097697A1 (es)
ZA (1) ZA201305059B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103113364B (zh) * 2012-08-27 2015-11-18 南京华威医药科技开发有限公司 阿齐沙坦多晶型的制备方法
CN103601723B (zh) * 2013-11-19 2016-04-27 合肥远志医药科技开发有限公司 一种阿齐沙坦的工业化生产方法
JP2017036215A (ja) * 2013-12-27 2017-02-16 トーアエイヨー株式会社 アンジオテンシンｉｉ受容体拮抗物質の塩
CN105037341B (zh) * 2014-04-04 2019-12-03 江苏豪森药业集团有限公司 阿齐沙坦醇铵晶型及其制备方法
CN105503848A (zh) * 2014-10-13 2016-04-20 江苏豪森药业集团有限公司 阿齐沙坦有机胺盐复合物及其制备方法和用途
CZ2014702A3 (cs) 2014-10-15 2016-04-27 Zentiva, K.S. Způsob přípravy vysoce čistého azilsartanu
CN108113988A (zh) * 2016-11-29 2018-06-05 江苏恒瑞医药股份有限公司 一种romk抑制剂与arb联合在制备治疗和/或预防高血压或心力衰竭的药物中的用途
CN107286145A (zh) * 2017-08-14 2017-10-24 广州奈米微晶生物科技有限公司 一种阿齐沙坦哌嗪盐溶剂合物及其制备方法与应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA924666B (en) * 1991-06-27 1993-12-24 Takeda Chemical Industries Ltd Heterocyclic compounds, their production and use
IL102183A (en) * 1991-06-27 1999-11-30 Takeda Chemical Industries Ltd The heterocyclic compounds are converted into biphenyl groups, their production and the pharmaceutical compositions containing them
CA2415962C (en) * 2000-07-19 2010-07-06 Novartis Ag Valsartan salts
JP4484427B2 (ja) * 2001-12-03 2010-06-16 武田薬品工業株式会社 インスリン抵抗性改善剤
US20050032854A1 (en) * 2001-12-03 2005-02-10 Kiminori Kawahara Insulin resistance improving agents
US7157584B2 (en) 2004-02-25 2007-01-02 Takeda Pharmaceutical Company Limited Benzimidazole derivative and use thereof
UY29155A1 (es) * 2004-10-07 2006-02-24 Takeda Pharmaceutical Un agente para la profilaxis o tratamietno del sindrome metabolico
SI22297A (sl) * 2006-06-23 2007-12-31 Krka, Tovarna Zdravil, D.D., Novo Mesto Priprava soli telmisartana
CZ2008469A3 (cs) * 2008-07-31 2009-10-29 Zentiva, A. S. Telmisartan tablety
WO2010075347A2 (en) 2008-12-23 2010-07-01 Takeda Pharmaceutical Company Limited Methods of treating hypertension with at least one angiotensin ii receptor blocker and chlorthalidone
CN101921264A (zh) * 2009-06-15 2010-12-22 江苏豪森医药集团有限公司 坎地沙坦有机胺盐及其制备方法和用途
JP2013512199A (ja) * 2009-11-30 2013-04-11 ジエンス ハンセン ファーマセウティカル カンパニー リミテッド アジルサルタン有機アミン塩、その製造方法及び使用

Also Published As

Publication number Publication date
US20130296334A1 (en) 2013-11-07
CN102603723A (zh) 2012-07-25
CA2824316C (en) 2020-07-07
RU2013137223A (ru) 2015-02-27
JP2014502978A (ja) 2014-02-06
AU2012208863A1 (en) 2013-08-01
HK1169826A1 (en) 2013-02-08
JP5981940B2 (ja) 2016-08-31
EP2666773A1 (en) 2013-11-27
EP2666773A4 (en) 2014-06-11
ZA201305059B (en) 2015-01-28
US9233954B2 (en) 2016-01-12
CN102603723B (zh) 2014-10-08
EP2666773A8 (en) 2014-02-12
RU2600986C2 (ru) 2016-10-27
CA2824316A1 (en) 2012-07-26
BR112013017982A2 (pt) 2020-10-27
MX340590B (es) 2016-07-13
WO2012097697A1 (zh) 2012-07-26
EP2666773B1 (en) 2017-07-26
TW201309684A (zh) 2013-03-01
AU2012208863B2 (en) 2016-07-28
TWI519531B (zh) 2016-02-01

Similar Documents

Publication Publication Date Title
MX340590B (es) Sales de aminas organicas de azilsartan, metodo de preparacion y uso de las mismas.
CY1119798T1 (el) Μορφη iv υδροχλωρικης ιβαμπραδινης
PH12016500072A1 (en) Piperidinyl-indole derivatives complement factor b inhibitors and uses thereof
TN2014000030A1 (en) Tetrahydropyrido-pyridine and tetrahydropyrido-pyrimidine compounds and use thereof as c5a receptor modulators
MX345928B (es) Composiciones terapeuticamente activas y metodos de uso de las mismas.
MA37400A1 (fr) Composés hétérocyclyle en tant qu'inhibiteurs de mek
MY165087A (en) Neprilysin inhibitors
MY162411A (en) Crystalline forms of a macrolide, and uses therefor
IN2015DN00185A (es)
MX2013008431A (es) Antagonista del receptor de mineralocorticoides.
WO2012117000A8 (en) 3-amino-pyridines as gpbar1 agonists
IL232035A (en) These heterocyclic compounds, these compounds as a medicine and a pharmaceutical composition containing them
WO2013004995A8 (en) Pyrimidinone compounds and their use
SG194463A1 (en) Glycoside derivatives and their uses for the treatment of diabetes
MY168212A (en) A new therapeutical composition containing apomorphine as active ingredient
MX2013002329A (es) Agonista de receptores de neutrofina y sus usos como medicamentos.
IL223872A (en) Pyrazoloquinoline derivatives and intermediates, process for preparation, use and pharmaceutical preparations and preparations containing them
MX2014010433A (es) Nueva forma cristalina de sulfato de sitagliptina.
MX2013011926A (es) Derivados de glicosido y usos de los mismos.
MX2014003701A (es) Compuestos para el tratamiento y profilaxis de enfermedad por el virus sincitial respiratorio.
TN2014000060A1 (en) Benzothiazolone compound
EP2781512A4 (en) OXADIAZOLE COMPOUND AND PROCESS FOR PREPARING THE SAME, PHARMACEUTICAL COMPOSITION AND USE THEREOF
IN2014DN10669A (es)
BR112014001425A2 (pt) forma de dosagem farmacêutica, composição farmacêutica, e, composto (i) ou sal farmaceuticamente aceitável do mesmo
ZA201309559B (en) Comptothecin derivative, method for preparing same, pharmaceutical composition and use thereof

Legal Events

Date Code Title Description
FG Grant or registration